[{"data":1,"prerenderedAt":264},["ShallowReactive",2],{"options:asyncdata:$edqCtX92v0:/blogs/the-critical-role-of-early-detection-in-preventing-cervical-cancer:0":3},{"blogPost":4,"otherBlogs":87},{"id":5,"date":6,"date_gmt":6,"guid":7,"modified":6,"modified_gmt":6,"slug":9,"status":10,"type":11,"link":12,"title":13,"content":15,"excerpt":18,"author":20,"featured_media":21,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":25,"categories":27,"tags":31,"class_list":32,"featured_media_src_url":42,"_links":43},571,"2026-01-08T06:05:35",{"rendered":8},"https://wp.ncikenya.go.ke/?p=571","the-critical-role-of-early-detection-in-preventing-cervical-cancer","publish","post","https://wp.ncikenya.go.ke/2026/01/08/the-critical-role-of-early-detection-in-preventing-cervical-cancer/",{"rendered":14},"The Critical Role of Early Detection in Preventing Cervical Cancer",{"rendered":16,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">Cervical cancer is unique because it is one of the most preventable and treatable forms of cancer, provided it is detected early. In Kenya, where cervical cancer remains the leading cause of cancer-related deaths among women, understanding the importance of early detection is a life-saving necessity.\u003C/p>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">1. Detection of Pre-Cancerous Lesions\u003C/h3>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Cervical cancer does not develop overnight. It typically takes years for persistent high-risk HPV infections to cause changes in cervical cells that eventually lead to cancer.\u003C/p>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>Early screening (via HPV DNA testing or Pap Smears) identifies these “pre-cancerous” lesions before they become malignant.\u003C/li>\n\n\n\n\u003Cli>When caught at this stage, simple outpatient procedures can remove the abnormal cells, effectively preventing cancer from ever developing.\u003C/li>\n\u003C/ul>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">2. Higher Survival Rates\u003C/h3>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The stage at which cancer is diagnosed is the single most important predictor of survival.\u003C/p>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Early Stage:\u003C/strong> When detected at an early, localized stage, the 5-year survival rate for cervical cancer is over \u003Cstrong>90%\u003C/strong>.\u003C/li>\n\n\n\n\u003Cli>\u003Cstrong>Late Stage:\u003C/strong> If the cancer has spread to distant organs (metastatic), the survival rate drops significantly to below \u003Cstrong>20%\u003C/strong>. In Kenya, many patients present with Stage III or IV disease, making early detection campaigns a national priority.\u003C/li>\n\u003C/ul>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">3. Less Invasive and More Affordable Treatment\u003C/h3>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Treatment for advanced cervical cancer often requires a combination of radical surgery, chemotherapy, and radiotherapy, which can be physically grueling and financially draining for families.\u003C/p>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Early Detection:\u003C/strong> Treatment for early-stage disease is often less invasive, preserves fertility in younger women, and has a much shorter recovery time.\u003C/li>\n\n\n\n\u003Cli>\u003Cstrong>Economic Impact:\u003C/strong> Early intervention is significantly cheaper than managing advanced-stage cancer. Under the \u003Cstrong>Social Health Authority (SHA)\u003C/strong>, early screening and localized treatments are far more cost-effective for both the patient and the healthcare system.\u003C/li>\n\u003C/ul>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">4. Quality of Life and Fertility Preservation\u003C/h3>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">For many women in their childbearing years, early detection offers the possibility of fertility-sparing treatments. Advanced cancer treatments often lead to premature menopause or the inability to carry a pregnancy. Early detection ensures that women can survive cancer while maintaining their quality of life and future family goals.\u003C/p>\n\n\n\n\u003Ch3 class=\"wp-block-heading\">5. Breaking the Cycle of Mortality in Kenya\u003C/h3>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">With roughly \u003Cstrong>9 women dying every day in Kenya\u003C/strong> from cervical cancer, early detection is the only way to break this cycle. By moving from “symptom-based” care to “screening-based” prevention, we can transform cervical cancer from a death sentence into a manageable—and eventually eliminated—health issue.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Conclusion:\u003C/strong> Early detection is not just a medical recommendation; it is an act of empowerment. It shifts the power from the disease back to the individual, ensuring that a diagnosis does not mean the end of a life, but the beginning of a successful recovery.\u003C/p>\n",false,{"rendered":19,"protected":17},"\u003Cp>Cervical cancer is unique because it is one of the most preventable and treatable forms of cancer, provided it is detected early. In Kenya, where cervical cancer remains the leading cause of cancer-related deaths among women, understanding the importance of early detection is a life-saving necessity. 1. Detection of Pre-Cancerous Lesions Cervical cancer does not […]\u003C/p>\n",1,572,"open","","standard",{"pagelayer_contact_templates":26,"_pagelayer_content":23,"footnotes":23},[],[28,29,30],3,9,26,[],[33,11,34,35,36,37,38,39,40,41],"post-571","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blogs","category-cancer-awareness","category-cervical-cancer","https://wp.ncikenya.go.ke/wp-content/uploads/2026/01/cerv-1024x1024.jpg",{"self":44,"collection":50,"about":53,"author":56,"replies":60,"version-history":63,"predecessor-version":66,"wp:featuredmedia":70,"wp:attachment":73,"wp:term":76,"curies":83},[45],{"href":46,"targetHints":47},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/571",{"allow":48},[49],"GET",[51],{"href":52},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts",[54],{"href":55},"https://wp.ncikenya.go.ke/wp-json/wp/v2/types/post",[57],{"embeddable":58,"href":59},true,"https://wp.ncikenya.go.ke/wp-json/wp/v2/users/1",[61],{"embeddable":58,"href":62},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=571",[64],{"count":20,"href":65},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/571/revisions",[67],{"id":68,"href":69},573,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/571/revisions/573",[71],{"embeddable":58,"href":72},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/572",[74],{"href":75},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=571",[77,80],{"taxonomy":78,"embeddable":58,"href":79},"category","https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=571",{"taxonomy":81,"embeddable":58,"href":82},"post_tag","https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=571",[84],{"name":85,"href":86,"templated":58},"wp","https://api.w.org/{rel}",[88,147,207],{"id":89,"date":90,"date_gmt":90,"guid":91,"modified":93,"modified_gmt":93,"slug":94,"status":10,"type":11,"link":95,"title":96,"content":98,"excerpt":100,"author":20,"featured_media":102,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":103,"categories":105,"tags":107,"class_list":108,"featured_media_src_url":111,"_links":112},721,"2026-09-25T17:34:12",{"rendered":92},"https://wp.ncikenya.go.ke/?p=721","2026-09-27T07:03:42","kenyas-efforts-to-advance-cancer-prevention-screening-early-detection-and-access-to-care","https://wp.ncikenya.go.ke/2026/09/25/kenyas-efforts-to-advance-cancer-prevention-screening-early-detection-and-access-to-care/",{"rendered":97},"Kenya’s Efforts to Advance Cancer Prevention, Screening, Early Detection and Access to Care.",{"rendered":99,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>25\u003Csup>th\u003C/sup> September, 2026 – Hong Kong, China\u003C/strong> — Presenting at the World Cancer Congress 2026, Emily Barsito, the Head of Strategic Planning, Resource Mobilization and Partnerships Directorate at NCI-Kenya, presented Kenya’s progress and experience in strengthening cancer prevention, screening, early detection and access to quality cancer care.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The presentation, \u003Cstrong>“Kenya’s Efforts on Cancer Prevention, Screening, Early Detection and Access to Care,”\u003C/strong> highlighted the country’s efforts to build a coordinated and equitable national cancer-control system, while drawing lessons that may be relevant to other low- and middle-income countries.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"1024\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734522-768x1024-1.jpg\" alt=\"\" class=\"wp-image-730\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734522-768x1024-1.jpg 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734522-225x300.jpg 225w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734522.jpg 960w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>Emily Barsito Presenting on Kenya’s  Efforts on Cancer Prevention, Screening, Early Detection and Access to Care\u003C/em>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Strengthening Cancer Prevention through Governance and Policy\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s response to the growing cancer burden is anchored in the \u003Cstrong>Cancer Prevention and Control Act, 2012\u003C/strong>, which established the National Cancer Institute of Kenya (NCI-K) to spearhead and coordinate cancer prevention and control nationally.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Through NCI-K and a multisectoral approach, Kenya continues to strengthen leadership and coordination in cancer prevention and control, public information, education and awareness, and implementation of the National Cancer Control Strategy.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Investing in Cancer Prevention\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Prevention remains a key pillar of Kenya’s cancer-control efforts.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Public information, education and awareness initiatives are being used to increase knowledge about cancer risk factors, prevention and the importance of screening, while creating demand for early detection services.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya has also strengthened tobacco control as an important public-health intervention, including restrictions on smoking in public spaces to reduce population exposure to tobacco smoke.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>HPV Vaccination and Cervical Cancer Prevention\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya continues to advance efforts towards the elimination of cervical cancer through HPV vaccination.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">More than \u003Cstrong>four million girls aged 9–14 years\u003C/strong> have been vaccinated through school-based programmes and integration of HPV vaccination into primary healthcare.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">This investment in prevention is critical to reducing the future burden of cervical cancer and protecting generations of Kenyan women.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Bringing Screening Closer to Communities\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya has integrated cancer screening with \u003Cstrong>primary healthcare (PHC)\u003C/strong> to improve access to preventive and early-detection services.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The country has also embraced innovative and culturally appropriate approaches to screening and awareness, including reaching underserved and hard-to-reach populations.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Integrating cancer prevention and screening into primary healthcare provides an opportunity to bring services closer to communities and strengthen early detection across the country.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Strengthening Early Detection and Diagnosis\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Early diagnosis remains essential to improving cancer outcomes.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya has invested in advanced oncology and diagnostic technologies, including \u003Cstrong>CT, MRI and PET-CT\u003C/strong>, to strengthen diagnosis, staging and treatment planning.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">These investments support the country’s ambition to shift cancer diagnosis from predominantly \u003Cstrong>Stage III and IV disease towards Stage I and II\u003C/strong>, when treatment can be more effective and outcomes improved.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Decentralising Cancer Care\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Access to quality cancer care is being strengthened through the decentralisation of oncology services and the establishment of \u003Cstrong>regional cancer centres\u003C/strong> capable of providing comprehensive cancer treatment.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">This approach is helping reduce geographical disparities and bringing specialised cancer services closer to patients and their families.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Sustainable health financing is equally important. Kenya’s \u003Cstrong>Universal Health Coverage (UHC)\u003C/strong> agenda and the \u003Cstrong>Social Health Insurance Fund (SHIF)\u003C/strong> oncology package are intended to reduce the financial burden associated with cancer treatment and protect families from catastrophic health expenditure.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Using Cancer Data to Guide Action\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Reliable data is fundamental to effective cancer prevention and control.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s \u003Cstrong>National Cancer Registry\u003C/strong> provides critical information to support evidence-based policy, planning, resource allocation, research and evaluation of cancer-control interventions.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Without reliable data, countries risk making decisions without a clear understanding of where the burden lies, who is affected and where resources are most needed.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Lessons for other Low- and Middle-Income Countries\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s experience offers several lessons that may be relevant to other countries facing similar challenges:\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>1. Good governance is essential.\u003C/strong>\u003Cbr>Strong leadership, coordination and accountability provide the backbone for resilient cancer-control systems.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>2. Prevention is the best investment.\u003C/strong>\u003Cbr>Countries should prioritise preventing cancers wherever effective prevention interventions are available.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>3. Decentralise cancer care.\u003C/strong>\u003Cbr>Bringing services closer to communities can reduce geographical and socioeconomic inequalities in access to care.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>4. Integrate cancer services with primary healthcare.\u003C/strong>\u003Cbr>Integration provides a practical pathway for expanding prevention, awareness and screening services.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>5. Invest in sustainable health financing.\u003C/strong>\u003Cbr>Cancer care should be accessible to those who need it, not only to those who can afford it.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>6. Build reliable cancer information systems.\u003C/strong>\u003Cbr>Cancer data is the lifeblood of effective planning, resource allocation and programme evaluation. Without it, decision-making remains largely blind.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>7. Leverage innovation to advance equity.\u003C/strong>\u003Cbr>Technology and innovation should be deliberately deployed to expand access, improve quality and address the needs of underserved populations.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>A shared commitment to cancer control\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Kenya’s experience demonstrates that progress in cancer control requires more than investment in treatment alone. It requires \u003Cstrong>strong governance, prevention, early detection, accessible screening, reliable data, sustainable financing, innovation and equitable access to care\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">As countries work towards reducing the growing global cancer burden, sharing experiences and learning from one another can help accelerate progress—particularly in low- and middle-income settings.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Kenya remains committed to strengthening its cancer-control systems and advancing equitable access to prevention, early detection and quality cancer care for all.\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>#NCIK #HealthGovernance #CancerPreventionAndControlAct #PublicHealthPolicy #CancerControl #CancerPrevention #CancerScreening #EarlyDetection #UniversalHealthCoverage\u003C/strong>\u003C/p>\n",{"rendered":101,"protected":17},"\u003Cp>25th September, 2026 – Hong Kong, China — Presenting at the World Cancer Congress 2026, Emily Barsito, the Head of Strategic Planning, Resource Mobilization and Partnerships Directorate at NCI-Kenya, presented Kenya’s progress and experience in strengthening cancer prevention, screening, early detection and access to quality cancer care. The presentation, “Kenya’s Efforts on Cancer Prevention, Screening, […]\u003C/p>\n",734,{"pagelayer_contact_templates":104,"_pagelayer_content":23,"footnotes":23},[],[106],4,[],[109,11,34,35,36,37,38,110],"post-721","category-news-updates","https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/734523-768x1024.jpg",{"self":113,"collection":118,"about":120,"author":122,"replies":124,"version-history":127,"predecessor-version":130,"wp:featuredmedia":134,"wp:attachment":137,"wp:term":140,"curies":145},[114],{"href":115,"targetHints":116},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/721",{"allow":117},[49],[119],{"href":52},[121],{"href":55},[123],{"embeddable":58,"href":59},[125],{"embeddable":58,"href":126},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=721",[128],{"count":106,"href":129},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/721/revisions",[131],{"id":132,"href":133},735,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/721/revisions/735",[135],{"embeddable":58,"href":136},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/734",[138],{"href":139},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=721",[141,143],{"taxonomy":78,"embeddable":58,"href":142},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=721",{"taxonomy":81,"embeddable":58,"href":144},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=721",[146],{"name":85,"href":86,"templated":58},{"id":148,"date":149,"date_gmt":149,"guid":150,"modified":152,"modified_gmt":152,"slug":153,"status":10,"type":11,"link":154,"title":155,"content":157,"excerpt":159,"author":20,"featured_media":161,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":162,"categories":164,"tags":166,"class_list":167,"featured_media_src_url":170,"_links":171},707,"2026-09-03T04:12:11",{"rendered":151},"https://wp.ncikenya.go.ke/?p=707","2026-09-03T06:18:42","university-of-manchester-team-visits-nci-k-to-explore-opportunities-for-cancer-research-and-capacity-building-collaboration","https://wp.ncikenya.go.ke/2026/09/03/university-of-manchester-team-visits-nci-k-to-explore-opportunities-for-cancer-research-and-capacity-building-collaboration/",{"rendered":156},"University of Manchester Team Visits NCI-K to Explore Opportunities for Cancer Research, Training and Capacity-Building Collaboration",{"rendered":158,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">The National Cancer Institute-Kenya (NCI-K) hosted a delegation from the University of Manchester and its cancer research and clinical partners for an engagement focused on strengthening collaboration in cancer research, screening, diagnostics, training, mentorship and capacity building.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The visiting team was received by the \u003Cstrong>NCI-K Chief Executive Officer\u003C/strong>, Dr. Elias Melly, who highlighted the Institute’s mandate and its ongoing efforts to strengthen cancer control through research, evidence generation, innovation and strategic partnerships.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large is-resized\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"759\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-1024x759.jpg\" alt=\"\" class=\"wp-image-712\" style=\"aspect-ratio:1.349195973329847;width:563px;height:auto\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-1024x759.jpg 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-300x222.jpg 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-767x568.jpg 767w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-1536x1138.jpg 1536w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5159-2048x1517.jpg 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cem>\u003Cstrong>From left,\u003C/strong> \u003Cstrong>Professor Sacha Howell – Division of Cancer Sciences; Professor Robert Bristow\u003C/strong> – \u003Cstrong>Director, Manchester Cancer Research Centre; Dr. Elias Melly, CEO, NCI-k\u003C/strong> and \u003Cstrong>Rachel Chown\u003C/strong> — \u003Cstrong>Associate Director, Integrated Research and Education Strategy, The Christie NHS Foundation Trust.\u003C/strong>\u003C/em>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">During the visit, the delegation was briefed on the \u003Cstrong>National Cancer Registry\u003C/strong>, including cancer data collection, analysis and reporting in Kenya. The team also received a presentation on the \u003Cstrong>NCI-K Cancer Data Dashboard\u003C/strong>, showcasing the latest available \u003Cstrong>2024 cancer data\u003C/strong> and its role in informing cancer planning, policy, research and service delivery.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The delegation was further taken through \u003Cstrong>research projects supported by NCI-K through its Seed Grant Programme\u003C/strong>, highlighting the Institute’s commitment to promoting locally relevant research and building Kenya’s cancer research capacity.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Exploring Areas of Strategic Collaboration\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Discussions focused on areas where the complementary strengths of NCI-K and the Manchester cancer research ecosystem could support advances across the cancer care and research continuum.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">A key area was \u003Cstrong>breast cancer screening and imaging\u003C/strong>, including strengthening national mammography services, improving screening uptake in rural and urban settings, and exploring the application of \u003Cstrong>artificial intelligence and machine learning in mammographic image interpretation and cancer detection\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The teams also explored opportunities for collaboration in \u003Cstrong>lung cancer screening\u003C/strong>, with a focus on generating evidence to inform appropriate screening approaches and strengthening early detection.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Other areas identified included \u003Cstrong>histopathology and diagnostic capacity\u003C/strong>, particularly through assessing skills gaps and developing targeted approaches to strengthen specialist expertise, laboratory capacity and cancer diagnostics.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Strengthening Training, Fellowships and Mentorship\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The engagement also explored opportunities for \u003Cstrong>fellowships, mentorship and structured training programmes\u003C/strong> for Kenyan researchers and healthcare professionals. Discussions included the development of \u003Cstrong>online learning modules, short-term training programmes and other flexible professional development opportunities\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">These areas align with Manchester’s established strength in cancer education, clinical research and workforce development. The Manchester Cancer Research Centre brings together \u003Cstrong>The University of Manchester, The Christie NHS Foundation Trust and Cancer Research UK\u003C/strong>, creating an integrated environment in which basic science, translational research and clinical practice are closely connected. The Centre’s research strategy spans multiple cancer types and links basic, translational and clinical research through a wider network of externally funded institutes, centres and research programmes.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Genomics, AI and Precision Cancer Research\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The discussions further identified opportunities for joint research in \u003Cstrong>genomics, artificial intelligence and machine learning\u003C/strong>, including the use of advanced technologies to improve cancer diagnosis, understand disease biology and support data-driven cancer research.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Manchester has significant expertise in \u003Cstrong>cancer genomics and data science\u003C/strong>, with ongoing international research programmes examining the genetic basis of cancer and opportunities to improve early detection and treatment. Importantly, Manchester already has an active research collaboration in \u003Cstrong>Kenya on oesophageal cancer\u003C/strong>, led by Professor Rob Bristow in partnership with Kenyan researchers, focusing on early detection and the genetic changes associated with oesophageal squamous cell cancer.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The teams also discussed opportunities to explore the application of \u003Cstrong>AI in research methodologies\u003C/strong>, including innovative approaches to study design and participant randomisation.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The engagement highlighted the potential for NCI-K and Manchester to build on complementary strengths: \u003Cstrong>NCI-K’s national cancer data, research mandate and understanding of Kenya’s cancer landscape\u003C/strong>, alongside Manchester’s expertise in \u003Cstrong>cancer genomics, precision oncology, imaging, artificial intelligence, clinical research, translational science, education and multidisciplinary cancer care\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The Manchester Cancer Research Centre is a world-leading comprehensive cancer research partnership, bringing together scientists, clinicians and research institutions to accelerate the translation of discoveries into improved cancer prevention, diagnosis and treatment. Its strong international outlook and existing collaborations in Kenya provide a valuable foundation for expanding research and capacity-building partnerships.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">NCI-K and the University of Manchester will continue discussions to translate the areas identified into practical programmes that can contribute to \u003Cstrong>strengthening cancer research, innovation, early detection, diagnostics, workforce development and cancer control in Kenya\u003C/strong>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>University of Manchester Delegation\u003C/strong>\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The delegation included:\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Rachel Chown\u003C/strong> — \u003Cstrong>Associate Director, Integrated Research and Education Strategy, The Christie NHS Foundation Trust.\u003C/strong> Rachel previously served at the Manchester Cancer Research Centre, where she led training and education and supported international links, academic collaborations, and research-related education programmes.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Professor Robert Bristow\u003C/strong> — \u003Cstrong>Director, Manchester Cancer Research Centre (MCRC); Director, Cancer Research UK Manchester Centre; University Professor of Cancer Studies, University of Manchester; and Senior Group Leader in Translational Oncogenomics at the Cancer Research UK Manchester Institute.\u003C/strong> Professor Bristow’s research includes cancer genomics, tumour biology, DNA damage and repair, and treatment response.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003Cstrong>Professor Sacha Howell\u003C/strong> is a professor in the Division of Cancer Sciences at the University of Manchester and a leading breast cancer clinician-researcher. His research focuses on breast cancer treatment and prevention, breast cancer risk prediction, imaging and mammographic density, with links to research in artificial intelligence and mammographic imaging.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">\u003C/p>\n",{"rendered":160,"protected":17},"\u003Cp>The National Cancer Institute-Kenya (NCI-K) hosted a delegation from the University of Manchester and its cancer research and clinical partners for an engagement focused on strengthening collaboration in cancer research, screening, diagnostics, training, mentorship and capacity building. The visiting team was received by the NCI-K Chief Executive Officer, Dr. Elias Melly, who highlighted the Institute’s […]\u003C/p>\n",708,{"pagelayer_contact_templates":163,"_pagelayer_content":23,"footnotes":23},[],[106,165],43,[],[168,11,34,35,36,37,38,110,169],"post-707","category-partnerships","https://wp.ncikenya.go.ke/wp-content/uploads/2026/09/DSC_5237-1024x683.jpg",{"self":172,"collection":177,"about":179,"author":181,"replies":183,"version-history":186,"predecessor-version":190,"wp:featuredmedia":194,"wp:attachment":197,"wp:term":200,"curies":205},[173],{"href":174,"targetHints":175},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/707",{"allow":176},[49],[178],{"href":52},[180],{"href":55},[182],{"embeddable":58,"href":59},[184],{"embeddable":58,"href":185},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=707",[187],{"count":188,"href":189},7,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/707/revisions",[191],{"id":192,"href":193},720,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/707/revisions/720",[195],{"embeddable":58,"href":196},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/708",[198],{"href":199},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=707",[201,203],{"taxonomy":78,"embeddable":58,"href":202},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=707",{"taxonomy":81,"embeddable":58,"href":204},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=707",[206],{"name":85,"href":86,"templated":58},{"id":208,"date":209,"date_gmt":209,"guid":210,"modified":209,"modified_gmt":209,"slug":212,"status":10,"type":11,"link":213,"title":214,"content":216,"excerpt":218,"author":20,"featured_media":220,"comment_status":22,"ping_status":22,"sticky":17,"template":23,"format":24,"meta":221,"categories":223,"tags":224,"class_list":225,"featured_media_src_url":227,"_links":228},669,"2026-05-29T07:10:19",{"rendered":211},"https://wp.ncikenya.go.ke/?p=669","kenya-advances-technology-driven-cancer-care","https://wp.ncikenya.go.ke/2026/05/29/kenya-advances-technology-driven-cancer-care/",{"rendered":215},"Kenya Advances Technology-Driven Cancer Care.",{"rendered":217,"protected":17},"\n\u003Cp class=\"wp-block-paragraph\">The Chief Executive Officer of the National Cancer Institute of Kenya (NCI-K), Dr. Elias Melly, joined the Cabinet Secretary for Health, Hon. Aden Duale, during a strategic engagement at Afya House with Prof. Eric Ford, Director and Vice-Chair of Medical Physics at the University of Washington and member of Bio Ventures for Global Health (BVGH), aimed at accelerating the transformation of Kenya’s cancer care system under the Universal Health Coverage agenda.\u003C/p>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"682\" src=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066876192-1-1024x682.jpeg\" alt=\"\" class=\"wp-image-671\" srcset=\"https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066876192-1-1024x682.jpeg 1024w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066876192-1-300x200.jpeg 300w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066876192-1-768x512.jpeg 768w, https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066876192-1.jpeg 1280w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" />\u003C/figure>\n\n\n\n\u003Cp class=\"has-text-align-center wp-block-paragraph\">\u003Cem>Health CS, Hon. Aden Duale, leading the meeting\u003C/em>.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The discussions focused on the growing role of AI-enabled technologies, including systems already in use at Kenyatta National Hospital, in improving diagnostic precision, strengthening clinical decision-making, and enhancing efficiency in oncology care delivery.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The meeting also explored expansion of radiotherapy services, strengthening referral linkages between national and regional cancer centres, digital learning platforms for specialized oncology training, early cancer detection through community health systems, and improved access to essential oncology medicines.\u003C/p>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The engagement reaffirmed a shared commitment to practical, technology-driven solutions that improve access, quality, and equity in cancer care delivery across the country. The Cabinet Secretary was joined by Dr. Stephen Muleshe, Director of Public Health and Sanitation, Dr. Isaak Bashir, Director of Family Health, and other senior Ministry of Health officials.\u003C/p>\n",{"rendered":219,"protected":17},"\u003Cp>The Chief Executive Officer of the National Cancer Institute of Kenya (NCI-K), Dr. Elias Melly, joined the Cabinet Secretary for Health, Hon. Aden Duale, during a strategic engagement at Afya House with Prof. Eric Ford, Director and Vice-Chair of Medical Physics at the University of Washington and member of Bio Ventures for Global Health (BVGH), […]\u003C/p>\n",672,{"pagelayer_contact_templates":222,"_pagelayer_content":23,"footnotes":23},[],[106,165],[],[226,11,34,35,36,37,38,110,169],"post-669","https://wp.ncikenya.go.ke/wp-content/uploads/2026/05/1778066874129-1024x679.jpeg",{"self":229,"collection":234,"about":236,"author":238,"replies":240,"version-history":243,"predecessor-version":247,"wp:featuredmedia":251,"wp:attachment":254,"wp:term":257,"curies":262},[230],{"href":231,"targetHints":232},"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/669",{"allow":233},[49],[235],{"href":52},[237],{"href":55},[239],{"embeddable":58,"href":59},[241],{"embeddable":58,"href":242},"https://wp.ncikenya.go.ke/wp-json/wp/v2/comments?post=669",[244],{"count":245,"href":246},2,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/669/revisions",[248],{"id":249,"href":250},674,"https://wp.ncikenya.go.ke/wp-json/wp/v2/posts/669/revisions/674",[252],{"embeddable":58,"href":253},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media/672",[255],{"href":256},"https://wp.ncikenya.go.ke/wp-json/wp/v2/media?parent=669",[258,260],{"taxonomy":78,"embeddable":58,"href":259},"https://wp.ncikenya.go.ke/wp-json/wp/v2/categories?post=669",{"taxonomy":81,"embeddable":58,"href":261},"https://wp.ncikenya.go.ke/wp-json/wp/v2/tags?post=669",[263],{"name":85,"href":86,"templated":58},1792071281006]